Drug Trial Radar · NCT03852719
Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)
Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Apr 17, 2019
Primary completion
Nov 26, 2020
Study completion Aug 8, 2024
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Feb 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy of bulevirtide administered subcutaneously (SC) for 48 weeks at a dose of 2 mg or 10 mg once daily for treatment of chronic hepatitis delta (CHD) in comparison to delayed treatment. The main goal of this study is to determine the effectiveness of bulevirtide in participants randomized to bulevirtide 2 mg or 10 mg once daily SC as compared to participants randomized to delayed treatment for 48 weeks. Treatment will continue through Week 144 (participants randomized to delayed treatment will change to bulevirtide 10 mg once daily SC after Week 48 through Week 144). All participants will be followed off-treatment for an additional 96 weeks.
Conditions
- Chronic Hepatitis Delta
Interventions
BulevirtideDrug
Administered via SC injections
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Combined Response at Week 48Time frame: Week 48
Locations
19 sites in 5 countries. Site status is shown where the registry gives one.
New York University School of Medicine, an administrative unit of New York University, an education corporation
New York, New York
Cornell University Well Madical College
New York, New York
Universitätsklinikum Essen (AoR), Klinik für Gastroenterologie und Hepatologie
Essen, Germany
Universitätsklinikum Frankfurt Medizinische Klinik 1
Frankfurt am Main, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie und Endokrinologie
Hanover, Germany
Heidelberg University Hospital, Departament of Gastroenterology, Infectious Diseases, Intoxication
Heidelberg, Germany
Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
Università di Modena e Reggio Emilia- Ospedale Civile S.
Modena, Italy
U.O. Epatologia - Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
State Budgetary Educational Institution of Higher Professional Education "South Ural State Medical University" of the Ministry of Healthcare of the Russian Federation
Chelyabinsk, Russia
Specialized clinical Infectious diseases Hospital
Krasnodar, Russia
Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance
Moscow, Russia
Federal State Budgetary Institution National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation
Moscow, Russia
LLC"Clinic of Modern Medicine"
Moscow, Russia
Moscow Regional Scientific and Research Clinical Institute
Moscow, Russia
LLC Medical Company "Hepatolog"
Samara, Russia
Stavropol Regional Hospital
Stavropol, Russia
Karolinska University Hospital Huddinge, Dept of Infectious Diseases
Stockholm, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.